American Century Companies Inc. Raises Stock Position in SI-BONE, Inc. (NASDAQ:SIBN)

American Century Companies Inc. boosted its position in SI-BONE, Inc. (NASDAQ:SIBN) by 11.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,378,068 shares of the company’s stock after purchasing an additional 236,167 shares during the quarter. American Century Companies Inc. owned about 5.67% of SI-BONE worth $33,341,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently bought and sold shares of the company. FMR LLC increased its holdings in shares of SI-BONE by 103.6% in the third quarter. FMR LLC now owns 2,354 shares of the company’s stock worth $33,000 after purchasing an additional 1,198 shares during the period. Mainstream Capital Management LLC purchased a new position in SI-BONE during the fourth quarter worth about $53,000. R Squared Ltd bought a new position in SI-BONE in the 4th quarter worth about $73,000. Walleye Capital LLC purchased a new stake in shares of SI-BONE in the 3rd quarter valued at about $144,000. Finally, Proficio Capital Partners LLC purchased a new stake in shares of SI-BONE in the 4th quarter valued at about $155,000. 98.11% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Truist Financial reaffirmed a “buy” rating and set a $22.00 price target (up previously from $18.00) on shares of SI-BONE in a research note on Tuesday, February 25th. Cantor Fitzgerald reissued an “overweight” rating and set a $25.00 price objective on shares of SI-BONE in a report on Tuesday, February 25th. Finally, Needham & Company LLC upped their target price on SI-BONE from $20.00 to $24.00 and gave the stock a “buy” rating in a research note on Tuesday, February 25th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $24.40.

SI-BONE Stock Up 0.4 %

Shares of NASDAQ:SIBN opened at $14.04 on Friday. The stock has a market capitalization of $596.04 million, a P/E ratio of -15.26 and a beta of 1.17. The stock’s 50-day moving average price is $16.41 and its 200-day moving average price is $14.78. The company has a current ratio of 8.25, a quick ratio of 7.22 and a debt-to-equity ratio of 0.22. SI-BONE, Inc. has a 12-month low of $11.70 and a 12-month high of $19.16.

SI-BONE (NASDAQ:SIBN) last posted its quarterly earnings results on Monday, February 24th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.16) by $0.05. SI-BONE had a negative return on equity of 22.51% and a negative net margin of 23.82%. The business had revenue of $49.00 million for the quarter, compared to analyst estimates of $48.87 million. On average, equities analysts anticipate that SI-BONE, Inc. will post -0.78 earnings per share for the current year.

Insider Transactions at SI-BONE

In related news, insider Anthony J. Recupero sold 3,670 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $13.90, for a total value of $51,013.00. Following the sale, the insider now directly owns 222,814 shares of the company’s stock, valued at $3,097,114.60. This trade represents a 1.62 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Anshul Maheshwari sold 5,304 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $13.91, for a total value of $73,778.64. Following the transaction, the chief financial officer now owns 189,319 shares in the company, valued at approximately $2,633,427.29. This represents a 2.73 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 9,311 shares of company stock worth $130,356. Insiders own 3.90% of the company’s stock.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.